321 related articles for article (PubMed ID: 7543773)
1. Stromal inhibition of prostatic epithelial cell proliferation not mediated by transforming growth factor beta.
Kooistra A; van den Eijnden-van Raaij AJ; Klaij IA; Romijn JC; Schröder FH
Br J Cancer; 1995 Aug; 72(2):427-34. PubMed ID: 7543773
[TBL] [Abstract][Full Text] [Related]
2. Stromal inhibition of epithelial cell growth in the prostate; overview of an experimental study.
Kooistra A; Romijn JC; Schröder FH
Urol Res; 1997; 25 Suppl 2():S97-105. PubMed ID: 9144894
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of prostatic epithelial cell proliferation by a factor secreted specifically by prostatic stromal cells.
Kooistra A; König JJ; Keizer DM; Romijn JC; Schröder FH
Prostate; 1995 Mar; 26(3):123-32. PubMed ID: 7899150
[TBL] [Abstract][Full Text] [Related]
4. Beta-2 microglobulin is mitogenic to PC-3 prostatic carcinoma cells and antagonistic to transforming growth factor beta 1 action.
Rowley DR; Dang TD; McBride L; Gerdes MJ; Lu B; Larsen M
Cancer Res; 1995 Feb; 55(4):781-6. PubMed ID: 7850789
[TBL] [Abstract][Full Text] [Related]
5. Dual regulation of proliferation and growth arrest in prostatic stromal cells by transforming growth factor-beta1.
Zhou W; Park I; Pins M; Kozlowski JM; Jovanovic B; Zhang J; Lee C; Ilio K
Endocrinology; 2003 Oct; 144(10):4280-4. PubMed ID: 12959966
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta induces growth inhibition and IGF-binding protein-3 production in prostatic stromal cells: abnormalities in cells cultured from benign prostatic hyperplasia tissues.
Cohen P; Nunn SE; Peehl DM
J Endocrinol; 2000 Feb; 164(2):215-23. PubMed ID: 10657857
[TBL] [Abstract][Full Text] [Related]
8. Expression of transforming growth factor beta 1 (TGF beta 1), -beta 2, and- beta 3 by cultured human prostate cells.
Story MT; Hopp KA; Molter M
J Cell Physiol; 1996 Oct; 169(1):97-107. PubMed ID: 8841426
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW
Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336
[TBL] [Abstract][Full Text] [Related]
11. Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta1.
Sakko AJ; Ricciardelli C; Mayne K; Tilley WD; Lebaron RG; Horsfall DJ
Cancer Res; 2001 Feb; 61(3):926-30. PubMed ID: 11221884
[TBL] [Abstract][Full Text] [Related]
12. Proliferation and differentiation of prostatic stromal cells.
Niu Y; Xu Y; Zhang J; Bai J; Yang H; Ma T
BJU Int; 2001 Mar; 87(4):386-93. PubMed ID: 11251536
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta expression in prostate neoplasia.
Cardillo MR; Petrangeli E; Perracchio L; Salvatori L; Ravenna L; Di Silverio F
Anal Quant Cytol Histol; 2000 Feb; 22(1):1-10. PubMed ID: 10696454
[TBL] [Abstract][Full Text] [Related]
14. Influence of transforming growth factor beta 1 and other growth factors on basic fibroblast growth factor level and proliferation of cultured human prostate-derived fibroblasts.
Story MT; Hopp KA; Meier DA; Begun FP; Lawson RK
Prostate; 1993; 22(3):183-97. PubMed ID: 7683814
[TBL] [Abstract][Full Text] [Related]
15. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.
Placencio VR; Sharif-Afshar AR; Li X; Huang H; Uwamariya C; Neilson EG; Shen MM; Matusik RJ; Hayward SW; Bhowmick NA
Cancer Res; 2008 Jun; 68(12):4709-18. PubMed ID: 18559517
[TBL] [Abstract][Full Text] [Related]
16. Isolation of a prostate carcinoma cell proliferation-inhibiting factor from human seminal plasma and its similarity to transforming growth factor beta.
Lokeshwar BL; Block NL
Cancer Res; 1992 Oct; 52(20):5821-5. PubMed ID: 1394210
[TBL] [Abstract][Full Text] [Related]
17. Peptide growth factors in the prostate as mediators of stromal epithelial interaction.
Byrne RL; Leung H; Neal DE
Br J Urol; 1996 May; 77(5):627-33. PubMed ID: 8689101
[TBL] [Abstract][Full Text] [Related]
18. Prostatic ductal system in rats: tissue-specific expression and regional variation in stromal distribution of transforming growth factor-beta 1.
Nemeth JA; Sensibar JA; White RR; Zelner DJ; Kim IY; Lee C
Prostate; 1997 Sep; 33(1):64-71. PubMed ID: 9294629
[TBL] [Abstract][Full Text] [Related]
19. Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6.
Degeorges A; Tatoud R; Fauvel-Lafeve F; Podgorniak MP; Millot G; de Cremoux P; Calvo F
Int J Cancer; 1996 Oct; 68(2):207-14. PubMed ID: 8900430
[TBL] [Abstract][Full Text] [Related]
20. A human prostatic stromal myofibroblast cell line WPMY-1: a model for stromal-epithelial interactions in prostatic neoplasia.
Webber MM; Trakul N; Thraves PS; Bello-DeOcampo D; Chu WW; Storto PD; Huard TK; Rhim JS; Williams DE
Carcinogenesis; 1999 Jul; 20(7):1185-92. PubMed ID: 10383888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
